• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5078129)   Today's Articles (443)
For: Stewart K, McGhan WF, Offerdahl T, Corey R. Overactive bladder patients and role of the pharmacist. J Am Pharm Assoc (Wash) 2002;42:469-76; quiz 477-8. [PMID: 12030634 DOI: 10.1331/108658002763316905] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Number Cited by Other Article(s)
1
Adverse Events for Overactive Bladder Medications From a Public Federal Database. Female Pelvic Med Reconstr Surg 2022;28:429-435. [PMID: 35536677 DOI: 10.1097/spv.0000000000001190] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
2
Beder D, Ashton P, Mishra V. Overactive bladder in women. BMJ 2021;375:e063526. [PMID: 34853012 DOI: 10.1136/bmj-2020-063526] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
3
MacDiarmid S, Al-Shukri S, Barkin J, Fianu-Jonasson A, Grise P, Herschorn S, Saleem T, Huang M, Siddiqui E, Stölzel M, Hemsted C, Nazir J, Hakimi Z, Drake MJ. Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy. J Urol 2016;196:809-18. [DOI: 10.1016/j.juro.2016.03.174] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/19/2016] [Indexed: 10/22/2022]
4
The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials. Qual Life Res 2015;24:1719-27. [PMID: 25688038 PMCID: PMC4483243 DOI: 10.1007/s11136-014-0904-4] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/17/2014] [Indexed: 11/03/2022]
5
Prasanthi D, Lakshmi PK. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder. Int Braz J Urol 2013;39:63-75; discussion 76. [PMID: 23489517 DOI: 10.1590/s1677-5538.ibju.2013.01.09] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2012] [Accepted: 09/24/2012] [Indexed: 11/21/2022]  Open
6
McCrery RJ, Smith PP, Appell RA. The emergence of new drugs for overactive bladder. Expert Opin Emerg Drugs 2006;11:125-36. [PMID: 16503831 DOI: 10.1517/14728214.11.1.125] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
7
Bhosle MJ, Wagner S, Ghantoji S, Balkrishnan R. Outcomes associated with pharmacotherapy in overactive bladder. Expert Rev Pharmacoecon Outcomes Res 2005;5:447-56. [PMID: 19807262 DOI: 10.1586/14737167.5.4.447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
8
Yu YF, Nichol MB, Yu AP, Ahn J. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program. VALUE IN HEALTH : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH 2005;8:495-505. [PMID: 16091027 DOI: 10.1111/j.1524-4733.2005.00041.x] [Citation(s) in RCA: 152] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
9
Nitti V, Taneja S. Overactive bladder: achieving a differential diagnosis from other lower urinary tract conditions. Int J Clin Pract 2005;59:825-30. [PMID: 15963211 DOI: 10.1111/j.1742-1241.2005.00490.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
10
Madersbacher H, Madersbacher S. Men's bladder health: urinary incontinence in the elderly (Part I). ACTA ACUST UNITED AC 2005. [DOI: 10.1016/j.jmhg.2005.01.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA